Real-World Evidence Solutions Market Growth 2023-2028

1
Global Real-World Evidence Solutions Market
Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Real-World Evidence Solutions Market
Research Report According to the latest report
by IMARC Group, titled Real-World Evidence
Solutions Market Global Industry Trends, Share,
Size, Growth, Opportunity and Forecast 2023-2028
the global real-world evidence solutions market
reached a strong growth in 2022.  Real-world
evidence (RWE) refers to clinical evidence about
the use and potential benefits or risks of
medical products via real-world data (RWD). It
can be produced via different study designs or
analyses, including randomized trials, big simple
trials, pragmatic trials, and observational
studies. It provides insight into real-world
treatment patterns in patient groups, including
dosing, compliance, adherence, off-label use, and
the balance between efficacy and safety. As it
can also assist researchers in discovering
possible patients and developing correct
inclusion criteria for clinical trials, which can
help them design better pre-trial studies, there
is a rise in the demand for RWE solutions around
the world. Request Free Sample Report
https//www.imarcgroup.com/real-world-evidence-sol
utions-market/requestsample
4
Report Description and Highlights
Report Description

Global Real-World Evidence Solutions Market
Trends The growing demand for RWE solutions to
get precise and clear information about the
safety and efficacy of new products represents
one of the key factors driving the market.
Moreover, there is a rise in the demand for these
solutions to detect varied reactions, product
subpopulation effects, and product value when
utilized by complex and comorbid patients. This,
along with the burgeoning healthcare industry, is
propelling the growth of the market.
Additionally, the growing utilization of advanced
analytics and technological solutions in RWE for
clinical development, commercialization, speed
innovation, and accelerating improvements in
healthcare outcomes is positively influencing the
market. Besides this, there are various
initiatives undertaken by governments of several
countries to promote the use of RWE solutions,
which provide the efficacy of drugs and vaccines.
This, coupled with a shift from volume to
value-based care, is offering lucrative growth
opportunities to industry investors. Apart from
this, the growing adoption of digitalization and
patient-centered virtual care is catalyzing the
demand for RWE solutions. Furthermore, there is
an increase in the prevalence of chronic
diseases, such as cancer, obesity, and diabetes,
across the globe. In line with this, the rising
delays in drug development and the subsequent
increase in development costs are bolstering the
growth of the market. Looking forward, the
market value is projected to reach a strong
growth during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Component C
linical Settings Data Claims Data
Patient-Powered Data Pharmacy Data
Others Breakup by Therapeutic Area
Oncology Immunology Neur
ology Cardiovascular Disease O
thers Breakup by End User Pharmaceutic
al and Medical Device Companies
Healthcare Payers Healthcare P
roviders

6
Report Description and Highlights
Report Description
Others Breakup by Region Nor
th America United States
Canada Asia-Pacific
China Japan
India South Korea
Australia Indonesia
Others Europe
Germany France
United Kingdom Italy
Spain

7
Report Description and Highlights
Report Description
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa
Note We are updating our reports, If you want
latest primary and secondary data (2023-2028)
with Cost Module, Business Strategy, Distribution
Channel, etc. Click request free sample report.

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Clinigen Limited Flatiron Health Inc. (Roche Holdi
  ng AG) ICON plc International Business Machines Co
  rporation IQVIA Optum Inc. (UnitedHealth Group Inc
  orporated) Oracle Corporation Parexel Internationa
  l Corporation PPD Inc. (Thermo Fisher Scientific I
  nc.) Sas Institute Inc. Syneos Health.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/real-world-evidence-sol
  utions-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us